Wealthcare Advisory Partners’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-90
Closed -$6K 754
2021
Q1
$6K Buy
+90
New +$6.99K ﹤0.01% 1585
2020
Q2
Sell
-40
Closed -$1K 468
2020
Q1
$1K Buy
+40
New +$896 ﹤0.01% 1366

Other funds holding CDNA

Wealthcare Advisory Partners's CDNA Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of CareDx (CDNA) in Q2 2021, closing a stake of 90 shares — an estimated $6K sold.

Wealthcare Advisory Partners first reported a position in CDNA in Q1 2020 and held it in 2 quarters. The position peaked at $6K in Q1 2021. 254 funds tracked by Wall St. Rank hold CDNA as of Q2 2021.

  • Wealthcare Advisory Partners reported no remaining CareDx position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 90 CareDx shares in Q2 2021, an estimated $6K.
  • Wealthcare Advisory Partners first reported a position in CareDx in Q1 2020 and held it in 2 quarters.
  • Wealthcare Advisory Partners's CareDx position peaked at $6K in Q1 2021.
  • 254 funds tracked by Wall St. Rank held CareDx as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.